OverviewChartProfileKey statisticsFinancialsTechnicalNewsTraderScreen

Ionis Pharmaceuticals Inc/  US4622221004  /

NASDAQ
2024-04-19  10:00:00 PM Chg. -0.1300 Volume Bid12:23:21 AM Ask12:23:21 AM High Low
40.6800USD -0.32% 846,040
Turnover: 22.36 mill.		 40.6800Bid Size: 200 42.4400Ask Size: 100 41.1550 40.3850
GlobeNewswire 03-06 New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) i...
GlobeNewswire 03-05 Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 F...
GlobeNewswire 02-23 Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positiv...
GlobeNewswire 01-08 Praxis Precision Medicines Provides Update on Advancing Clinical Stage Portfolio
TeleTrader 2023-12-22 US FDA approves AstraZeneca-Ionis's medicine
GlobeNewswire 2022-03-28 Biogen and Ionis Announce Topline Phase 1 Study Results of Investigational Drug in C9orf72 Amyotroph...
GlobeNewswire 2022-03-17 Ring Therapeutics Announces the Appointment of Industry Leaders to its Board of Directors
GlobeNewswire 2022-03-14 Biogen Announces New Updates Across its SMA Research Program at 2022 MDA Conference
GlobeNewswire 2022-03-09 Antisense Therapeutics to present poster at world’s largest NMD conference
GlobeNewswire 2022-02-24 ProQR Announces Fourth Quarter and Full Year 2021 Operating and Financial Results
GlobeNewswire 2022-02-02 n-Lorem Foundation Partners with Argonaut to Manufacture ASO Medicines for Patients with Nano-rare D...
GlobeNewswire 2022-01-04 Biogen Exercises Option with Ionis to Develop and Commercialize Investigational ASO for SMA
GlobeNewswire 2022-01-03 Indaptus Therapeutics Announces Appointment of Boyan Litchev, M.D. as Chief Medical Officer
GlobeNewswire 2021-12-10 Cytokinetics Announces Data From Its ALS Program Presented at the 32nd International Symposium on AL...
GlobeNewswire 2021-11-18 ProQR Announces Highlights from Analyst Event
GlobeNewswire 2021-11-15 CoImmune, Inc. Appoints Ed Baracchini, PhD, Chairman of the Board of Directors
GlobeNewswire 2021-11-04 ProQR Announces Third Quarter 2021 Operating and Financial Results
GlobeNewswire 2021-10-17 Biogen Announces Topline Results from the Tofersen Phase 3 Study and its Open-Label Extension in SOD...
GlobeNewswire 2021-10-14 Topline Results from Tofersen Phase 3 Study and its Open Label Extension in SOD1-ALS to be Presented...
GlobeNewswire 2021-10-13 Progenity Announces Several Patents Granted by USPTO, Strengthening the Company’s Intellectual Prope...
GlobeNewswire 2021-09-21 Biogen R&D Day to Provide Overview of Diversified Pipeline and Capabilities with Potential for Multi...
GlobeNewswire 2021-09-21 Progenity to Participate in 11th Annual Partnership Opportunities in Drug Delivery Conference
GlobeNewswire 2021-09-15 Biogen Plans to Initiate Phase 3b Study Evaluating Potential Benefit of a Higher Dose of Nusinersen ...
GlobeNewswire 2021-09-08 Eloxx Pharmaceuticals Appoints Chief Medical Officer
GlobeNewswire 2021-08-05 ProQR Announces Second Quarter 2021 Operating and Financial Results